Franklin Hospital Corporation
Franklin Hospital Corporation was paid $1.92M by Medicaid between Jan 2018 and Dec 2019, across 106 billing codes. Its largest line is 99283, emergency room visit (moderate) — 22% of everything it billed.
FRANKLIN, VA 23851
Next to other General Acute Care Hospital providers in Virginia
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 34,619 | $726K | |
| 2019 | 46,511 | $1.19M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 22% | 4,682 | 4,008 | $425K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 21% | 3,813 | 3,097 | $398K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 12% | 2,052 | 1,585 | $222K |
| 96361 | Intravenous infusion, hydration; each additional hour | 5.8% | 1,148 | 909 | $111K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 5.2% | 1,126 | 1,029 | $99K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 4.9% | 3,327 | 680 | $93K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 4.2% | 855 | 779 | $81K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 3.4% | 782 | 627 | $64K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.2% | 445 | 359 | $61K |
| 70450 | Computed tomography, head or brain; without contrast material | 3.1% | 851 | 650 | $59K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.0% | 296 | 252 | $38K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.5% | 247 | 208 | $28K |
94 more codes
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 1.5% | 295 | $28K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 1.4% | 903 | $27K |
| G0378 | Hospital observation service, per hour | 1.3% | 672 | $25K |
| 71046 | Radiologic examination, chest; 2 views | 1.0% | 2,082 | $20K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 3,784 | $15K |
| 80053 | Comprehensive metabolic panel | <1% | 2,943 | $12K |
| 87400 | <1% | 1,525 | $11K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 675 | $9K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 188 | $8K |
| 84484 | <1% | 2,734 | $7K | |
| 97161 | <1% | 279 | $6K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,136 | $5K |
| 83690 | <1% | 977 | $5K | |
| 83880 | <1% | 694 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,865 | $5K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 5,898 | $5K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,858 | $3K |
| 81001 | <1% | 3,138 | $3K | |
| 80061 | Lipid panel | <1% | 796 | $3K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 15 | $2K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,169 | $2K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,185 | $2K |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 115 | $2K |
| 82553 | <1% | 758 | $2K | |
| 83605 | <1% | 680 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 472 | $1K |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | <1% | 572 | $1K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 855 | $1K |
| 73564 | <1% | 91 | $1K | |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 346 | $1K |
| 86756 | <1% | 79 | $1K | |
| 81025 | <1% | 909 | $1K | |
| 83874 | <1% | 374 | $860.28 | |
| 85378 | <1% | 242 | $828.93 | |
| 76536 | <1% | 14 | $828.18 | |
| 74018 | <1% | 74 | $826.25 | |
| 80076 | <1% | 15 | $760.74 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 789 | $752.27 |
| 83735 | <1% | 1,096 | $744.40 | |
| 82550 | <1% | 905 | $734.15 | |
| 85027 | <1% | 630 | $666.45 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 115 | $665.53 |
| J3490 | Unclassified drugs | <1% | 3,496 | $624.47 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 110 | $575.95 |
| 73630 | <1% | 34 | $465.29 | |
| 87040 | <1% | 78 | $416.24 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 1,075 | $303.17 |
| 73030 | <1% | 34 | $288.14 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 869 | $267.80 |
| 87077 | <1% | 120 | $229.59 | |
| 97116 | <1% | 51 | $221.72 | |
| 87186 | <1% | 417 | $221.09 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,130 | $212.43 |
| 72110 | <1% | 14 | $175.13 | |
| 84702 | <1% | 93 | $125.64 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,339 | $116.17 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 373 | $91.16 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | <1% | 39 | $84.04 |
| 85610 | <1% | 727 | $82.30 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 443 | $68.42 |
| 82150 | <1% | 77 | $53.34 | |
| 84466 | <1% | 14 | $50.73 | |
| 82607 | <1% | 14 | $48.09 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 446 | $46.64 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 305 | $43.41 |
| 85730 | <1% | 139 | $43.07 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 477 | $36.37 |
| 83540 | <1% | 30 | $27.24 | |
| 82728 | <1% | 13 | $26.96 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 209 | $25.86 |
| 94760 | <1% | 94 | $23.36 | |
| J2704 | Injection, propofol, 10 mg | <1% | 653 | $18.18 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 86 | $17.45 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 102 | $16.28 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 112 | $11.39 |
| 84439 | <1% | 12 | $10.45 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 103 | $8.91 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 127 | $7.19 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 44 | $3.94 |
| J3475 | Injection, magnesium sulfate, per 500 mg | <1% | 68 | $3.94 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 36 | $3.49 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 17 | $1.39 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 21 | $1.15 |
| C9113 | Injection, pantoprazole sodium, per vial | <1% | 14 | $0.46 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | <1% | 16 | $0.01 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 564 | $0.00 |
| 87210 | 0% | 33 | $0.00 | |
| 86900 | 0% | 33 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 39 | $0.00 |
| 96376 | 0% | 37 | $0.00 | |
| 86901 | 0% | 33 | $0.00 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 0% | 27 | $0.00 |
| 73502 | 0% | 20 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 107 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Northwest Hospital LLC | Tucson, AZ | $47.81M |
| Roswell Hospital Corporation | Roswell, NM | $41.27M |
| Wesley Health System LLC | Hattiesburg, MS | $37.82M |
| Metro Knoxville Hma LLC | Powell, TN | $28.70M |
| Bullhead City Hospital Corporation | Bullhead City, AZ | $28.54M |
| Iom Health System LP | Fort Wayne, IN | $27.50M |
| ST. Joseph Health System, LLC | Fort Wayne, IN | $25.43M |
| Laredo Texas Hospital Company LP | Laredo, TX | $19.46M |
| Oak Hill Hospital Corporation | Oak Hill, WV | $18.77M |
| Cocke County Hma, LLC | Newport, TN | $18.34M |
| Cleveland Tennessee Hospital Company LLC | Cleveland, TN | $16.31M |
| Jefferson County Hma LLC | Jefferson City, TN | $14.31M |
| Northwest Arkansas Hospitals, LLC | Springdale, AR | $11.46M |
| Petersburg Hospital Company LLC | Petersburg, VA | $11.20M |
| Campbell County Hma, LLC | Lafollette, TN | $10.07M |
| Warsaw Health System LLC | Warsaw, IN | $9.95M |
| Longview Medical Center LP | Longview, TX | $9.29M |
| Moberly Hospital Company LLC | Moberly, MO | $8.61M |
| Crestview Hospital Company, LLC | Crestview, FL | $8.15M |
| Kirksville Missouri Hospital Company, LLC | Kirksville, MO | $7.98M |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.